Many hematologic and solid tumors have elevated XPO-1 levels [34–37] with a strong correlation between increased XPO-1 expression and poor prognosis, as demonstrated in osteosarcoma [38], pancreatic [39], lung [35] and ovarian cancers [34]. Here, XPO1 is linked to ovarian cancer.